We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.75B
1-Year Est. Return 68.58%
This Fund
S&P 500
This Quarter Est. Return
-14.83%
1 Year Est. Return
+68.58%
3 Year Est. Return
+159.39%
5 Year Est. Return
+187.79%
10 Year Est. Return
+1,025.09%
AUM
$5.16B
AUM Growth
-$1.15B
Cap. Flow
+$52.2M
Cap. Flow %
1.01%
Top 10 Hldgs %
40.75%
Holding
232
New
16
Increased
80
Reduced
52
Closed
17

Top Buys

Rank Stock Value
1
BDTX icon
Black Diamond Therapeutics
BDTX
+$40.5M
2
FATE icon
Fate Therapeutics
FATE
+$37.4M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$29.7M
4
ESPR
Esperion Therapeutics
ESPR
+$27.1M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$25.4M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$63.8M
2
BMY icon
Bristol-Myers Squibb
BMY
+$54M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$26.7M
4
MRNA icon
Moderna
MRNA
+$22.7M
5
ALGN icon
Align Technology
ALGN
+$18.1M

Sector Composition

Rank Sector Weight
1 Healthcare 98.43%
2 Technology 0.56%
3 Industrials 0.54%
4 Communication Services 0.17%
5 Financials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPGI icon
176
S&P Global
SPGI
$131B
$417K 0.01%
1,700
– –
CSGP icon
177
CoStar Group
CSGP
$12.5B
$411K 0.01%
+7,000
New +$456K
SQM icon
178
Sociedad Química y Minera de Chile
SQM
$21.8B
$410K 0.01%
18,200
– –
IBKR icon
179
Interactive Brokers
IBKR
$42B
$406K 0.01%
37,600
– –
CL icon
180
Colgate-Palmolive
CL
$70.8B
$405K 0.01%
6,100
– –
MKC icon
181
McCormick & Company Non-Voting
MKC
$14B
$395K 0.01%
5,600
– –
HTHT icon
182
Huazhu Hotels Group
HTHT
$14.1B
$388K 0.01%
13,500
– –
ICE icon
183
Intercontinental Exchange
ICE
$90.5B
$388K 0.01%
4,800
– –
IPGP icon
184
IPG Photonics
IPGP
$3.32B
$386K 0.01%
3,500
– –
VRSN icon
185
VeriSign
VRSN
$26.4B
$378K 0.01%
2,100
– –
TRMB icon
186
Trimble
TRMB
$13.9B
$372K 0.01%
11,700
– –
MKL icon
187
Markel Group
MKL
$22.6B
$371K 0.01%
400
– –
ADI icon
188
Analog Devices
ADI
$176B
$368K 0.01%
4,100
– –
RVTY icon
189
Revvity
RVTY
$14.5B
$361K 0.01%
4,800
– –
EL icon
190
Estee Lauder
EL
$37.6B
$358K 0.01%
2,248
– –
MTCH icon
191
Match Group
MTCH
$9.61B
$350K 0.01%
+5,300
New +$390K
VRSK icon
192
Verisk Analytics
VRSK
$24.2B
$347K 0.01%
2,489
– –
PAYX icon
193
Paychex
PAYX
$43.3B
$340K 0.01%
5,400
– –
LABU icon
194
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$569M
$338K 0.01%
+750
New +$682K
TRU icon
195
TransUnion
TRU
$15.3B
$337K 0.01%
5,096
– –
SCI icon
196
Service Corp International
SCI
$11.2B
$332K 0.01%
8,500
– –
XLNX
197
DELISTED
Xilinx Inc
XLNX
$327K 0.01%
4,200
– –
BR icon
198
Broadridge
BR
$19.7B
$322K 0.01%
3,400
– –
ALV icon
199
Autoliv
ALV
$9.17B
$313K 0.01%
6,800
– –
MTB icon
200
M&T Bank
MTB
$34.6B
$310K 0.01%
3,000
– –
6 7
8
9 10

Similar funds

SP
Stockbridge Partners Boston, Massachusetts $4.75B AUM 18.52% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.76B AUM 23.76% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 20.5% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
NHC
Nicholas Hoffman & Company Atlanta, Georgia $4.74B AUM 18.12% 1-Year Est. Return
PTC
Provident Trust Company Waukesha, Wisconsin $4.77B AUM 29.31% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Bellevue Group's Q1 2020 Portfolio in Review

As of Q1 2020, Bellevue Group held 232 positions worth $5.16B, down 18% from $6.31B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Bellevue Group's Q1 2020 filing shows 16 new, 80 increased, 52 reduced and 17 closed positions. Its largest new stake was Black Diamond Therapeutics: 1,330,000 shares worth $33.2M. The largest sale was Teladoc Health, an estimated $63.8M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 99% a quarter earlier, followed by Technology and Industrials.

  • Bellevue Group's largest Q1 2020 buy was Black Diamond Therapeutics: 1,330,000 shares worth $33.2M.
  • Bellevue Group added most to Fate Therapeutics in Q1 2020, an estimated $37.4M increase.
  • Bellevue Group's biggest Q1 2020 reduction was Teladoc Health, cutting an estimated $63.8M.
  • Bellevue Group fully exited Wright Medical Group Inc in Q1 2020, selling an estimated $17.1M.
  • Bellevue Group's ten largest holdings make up 41% of its $5.16B portfolio in Q1 2020.
  • Bellevue Group opened 16 new positions and closed 17 in Q1 2020.
  • Bellevue Group's portfolio value fell 18% quarter-over-quarter to $5.16B.

Based on Bellevue Group's 13F filing for Q1 2020, filed 14 May 2020.